Gayle, S., Landrette, S., Beeharry, N., Conrad, C., Hernandez, M., Beckett, P., . . . Lichenstein, H. (2017, March 30). Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma. Retrieved November 04, 2020, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766845/ doi: 10.1182/blood-2016-09-736892